Idenix Pharmaceuticals (NASDAQ: IDIX ) shares fell 8.70% to $4.20 in the pre-market trading after the company lost its first phase of a patent dispute with Gilead Sciences (NASDAQ: GILD ). United Therapeutics (NASDAQ: UTHR ) dipped 6.87% to $56.76 in the pre-market session after the FDA declined